Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-17-000632
Filing Date
2017-11-08
Accepted
2017-11-08 16:59:12
Documents
35
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q optec_10q-093017.htm 10-Q 271417
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 8619
3 EXHIBIT 32.1 ex32x1.htm EX-32.1 5846
  Complete submission text file 0001079973-17-000632.txt   1185983

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT opti-20170930.xml EX-101.INS 161406
5 XBRL TAXONOMY EXTENSION SCHEMA opti-20170930.xsd EX-101.SCH 15346
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opti-20170930_cal.xml EX-101.CAL 23941
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opti-20170930_def.xml EX-101.DEF 27950
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE opti-20170930_lab.xml EX-101.LAB 95594
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opti-20170930_pre.xml EX-101.PRE 74382
Mailing Address 2173 SALK AVENUE SUITE 250 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250 CARLSBAD CA 92008 760-456-5777
Optec International, Inc. (Filer) CIK: 0001557340 (see all company filings)

EIN.: 455552519 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55861 | Film No.: 171187342
SIC: 2834 Pharmaceutical Preparations